Phenobarbital Market, By Indication, By Dosage Form, By Distribution Channel, By Geography

Description

Global Phenobarbital Market size is estimated to be valued at US$ 1.58 billion in 2023 and is expected to reach US$ 2.23 billion by 2030, by exhibiting a compound annual growth rate (CAGR) of 5% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1.58 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.00%	2030 Value Projection:	US$ 2.23 Bn

Figure 1. Global Phenobarbital Market Share (%), By Region, 2023

Phenobarbital is a medicine which is used to treat or prevent seizures. It works by regulating the abnormal electrical activity in the brain that causes seizures. It is a class of medications called anticonvulsants and sedatives. It is also sometimes used for to help a person relax or sleep when he/she is anxious or nervous. This medication is available only with a doctor's prescription.

There is risk associated with the use of this medication if it is used for a long time. These include problems with how the body uses or absorbs certain nutrients (e.g., calcium, B vitamins, folic acid, and vitamin D). It can also lower the blood levels of phosphate, an electrolyte that is important for normal cell function. Long-term use of this medication can also cause problems with thyroid hormones.

Market Dynamics

Phenobarbital is well-known for its effectiveness in the management of epilepsy and seizure disorders. It is regarded as a first-line treatment for several types of seizures, especially in areas with limited resources. The drug's ability to effectively stop seizures fuels demand for and use of it on the market.

The market for phenobarbital is constrained by the availability of substitute anti-epileptic medications with enhanced safety profiles and fewer adverse effects. There are additional alternatives for treating epilepsy and seizure disorders which is due to the development of new drugs with various mechanisms of action and focused indications. Especially, in situations when limiting adverse effects or drug interactions is important, healthcare practitioners may choose to prescribe these newer medications over phenobarbital.

Key features of the study:

This report provides an in-depth analysis of the global phenobarbital market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global phenobarbital market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Pfizer Inc., Novartis AG, H. Lundbeck A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Cipla Ltd., and Par Pharmaceutical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global phenobarbital market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global phenobarbital market

Global Phenobarbital Market Detailed Segmentation:

By Indication
- Epilepsy
- Neonatal Seizures
By Dosage Form
- Tablets
- Capsules
- Injectables
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top Companies in the Global Phenobarbital Market
- Sanofi
- Pfizer Inc.
- Novartis AG
- Lundbeck A/S
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals
- Cipla Ltd.
- Par Pharmaceutical

Product Code: CMI6024

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of epilepsy
- Restraints
Availability of alternative anti-epileptic Drugs
Adverse effects and safety concerns
- Opportunities
Increasing prevalence of neonatal seizures
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Phenobarbital Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Phenobarbital Market, By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Neonatal Seizures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

6. Global Phenobarbital Market, By Dosage Form, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

7. Global Phenobarbital Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Phenobarbital Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
India
China
Japan
Australia
ASEAN
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030 (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030 (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Pfizer Inc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Novartis AG.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Lundbeck A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Hikma Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Cipla Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Par Pharmaceutical
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Analysts' Views

10. Section

References
Research Methodology
About us